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To the Editor: In a recent issue of Kidney International, Lin
et al.1 demonstrated that the advanced glycation end
products (AGE) induce the same signaling events in rat
mesangial cells as induced by high glucose culminating in
increased expression of fibronectin and transforming growth
factor-b1. They found that both high glucose and AGE
increase Ras-dependent and nicotinamide adenine dinucleo-
tide phosphate (reduced form) oxidase-mediated superoxide
production and subsequently induce cytosolic extracellular
signal-regulated protein kinase and nuclear c-Jun activation,
leading to extracellular matrix accumulation.
The cellular handling of glucose is different from that of
AGE, because the involved receptors and metabolic pathways
are completely different. Therefore, it is surprising that
glucose and AGE induce exactly the same signaling pathways
in mesangial cells. As high glucose can rapidly form
intracellular AGE,2 one probable explanation could be that
the high glucose-induced signaling events in the mesangial
cells were actually mediated by AGE derived from glucose in
the study by Lin et al.1 However, the experimental conditions
utilized by Lin et al. raise some serious concerns. Mesangial
cells were treated with very high concentrations of D-glucose
and AGE (35 mM and 100mg/ml, respectively), and the
findings were compared with those of the vehicle-treated
condition. Lin et al.1 neither included a control substance, like
L-glucose or mannitol as a control for D-glucose, or bovine
serum albumin as a control for AGE in the experiments, nor
did they test the effects of 5 mM glucose in the mesangial cells.
Therefore, it is uncertain whether the signaling pathways
induced by high glucose and AGE reflect the characteristics of
these substances or the same signaling pathways could be
induced simply by osmotic/toxic effect of any substance.
Another methodological issue that has also drawn our
attention is the measurement of 8-hydroxy-20-deoxyguano-
sine (8-OHdG) by immunoblotting. To our knowledge, the
antibody against 8-OHdG has not been tested for immuno-
blotting, and the DNA fragments containing the modified
base 8-OHdG in tissue homogenate is unlikely to be detected
as a specific band in immunoblot. Lin et al.1 demonstrated a
single band, but did not mention the approximate molecular
weight of the band they considered for 8-OHdG.
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We thank Dr Biswas et al.1 for their interest in our recently
published work of high glucose and advanced glycation end
products raise Ras- and extracellular signal-regulated
kinases-dependent fibronectin accumulation of mesangial
cells.2 Their comments reflect the multiple signal transduc-
tion pathways in high glucose and advanced glycation end
products induction of oxidative stress and renal fibrosis
factor expression in mesangial cells. To this interesting
issue, the protocols of in vitro advanced glycation end
products (100 lM)- and high glucose (35 mM)-stressed
mesangial cells have been well established. We would refer
them to some recently published articles.3–5 It is not
surprising then that high glucose and advanced glycation
end products share similar molecular mechanisms to induce
fibrosis factor expression when basal medium (10% fetal
bovine serum and Dulbecco’s modified Eagle’s medium
constituting 5 mM D-glucose) with or without 35 mM
mannitol do not raise superoxide burst in our study model.
We note immunohistochemically and by immunoblot-
ting exogenous superoxide dismutases alleviation of
8-hydroxy-20-deoxyguanosine levels in diabetic kidney in
vivo. The provided protein band corresponding to 26 kDa
is one of the evident oxidative damaged molecules
containing 8-hydroxy-20-deoxyguanosine immunoreactiv-
ities in the diabetic kidney homogenate. The study
emphasizes the early control of oxidative stress in
preventing diabetes-induced fibrosis-promoting factor
accumulation of renal tissue.
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